ClearPoint Neuro, Inc. (CLPT) › Capital ExpendituresClearPoint Neuro, Inc. (CLPT) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2010: $61.7K2011: $26.1K2012: $127.5K2013: $74.5K2014: $48.1K2015: $76.9K2016: $101.0K2017: $26.8K2018: $63.5K2019: $10.0K2020: $41.0K2021: $168.0K2022: $253.0K2023: $717.0K2024: $275.0K2025: $522.0K$522.0K2010Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$522.0K+89.8%2024$275.0K-61.6%2023$717.0K+183.4%2022$253.0K+50.6%2021$168.0K+309.8%2020$41.0K+310.0%2019$10.0K-84.2%2018$63.5K+137.3%2017$26.8K-73.5%2016$101.0K+31.4%2015$76.9K+59.7%2014$48.1K-35.4%2013$74.5K-41.6%2012$127.5K+388.3%2011$26.1K-57.7%2010$61.7K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share